On ECHEMI
Home > Drugs > Sodium hyaluronate injection

Sodium hyaluronate injection

Function and Efficacy

Sodium hyaluronate is the main component of synovial fluid and one of the components of cartilage matrix. It plays a lubricating role in the joint cavity, reducing friction between tissues, and at the same time plays an elastic role, buffering the effect of stress on articular cartilage, and exerting its due physiological function. Injecting high molecular weight, high concentration, and high viscoelastic sodium hyaluronate into the joint cavity can significantly improve the inflammatory response of synovial tissue, increase the sodium hyaluronate content in the synovial fluid, enhance the viscosity and lubrication function of the joint fluid, protect the articular cartilage, promote the healing and regeneration of articular cartilage, relieve pain, and increase joint mobility.

Ingredients

The main ingredient of this product is sodium hyaluronate.

Name Description Content CAS NO. Manufacturer
Sodium hyaluronateIngredients

Sodium hyaluronate is the main component of synovial fluid and one of the components of cartilage matrix. It plays a lubricating role in the joint cavity, reducing friction between tissues, and at the same time plays an elastic role, buffering the effect of stress on articular cartilage, and exerting its due physiological function. Injecting high molecular weight, high concentration, and high viscoelastic sodium hyaluronate into the joint cavity can significantly improve the inflammatory response of synovial tissue, increase the sodium hyaluronate content in the synovial fluid, enhance the viscosity and lubrication function of the joint fluid, protect the articular cartilage, promote the healing and regeneration of articular cartilage, relieve pain, and increase joint mobility.

More
9067-32-7 33

Appearance

This product is a colorless, clear, viscous liquid.

Indication

Knee osteoarthritis, frozen shoulder, etc.

Usage and Dosage

This product is a drug for improving knee osteoarthritis, frozen shoulder and other symptoms. When used for knee osteoarthritis, it is injected into the knee joint cavity; when used for frozen shoulder, it is injected into the shoulder joint cavity or subacromial bursa. 2mi each time, once a week, 5 weeks as a course of treatment

Adverse Reactions

Some patients may experience symptoms such as pain, rash, and itching at the injection site, which usually disappear on their own within 2-3 days. If the symptoms persist, the medication should be stopped and necessary treatment should be carried out.

Special Population Medication

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

Drug Interactions

Not yet clear.

Storage

Keep in a dark place and sealed at 2-8℃.

Packaging Specification

2 ml: 20 mg

Validity Period

Tentative two years

Manufacturer

Shandong Bausch & Lomb Freda Pharmaceutical Co., Ltd.

  • Founded in:

    1992-03-31
  • Address:

    No. 789, Xinluo Street, Jinan High-tech Development Zone
  • Tax NO.:

    913701006140705563
  • Registered Funds:

    90 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.